查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513910

商业生物技术分离系统的全球市场

Commercial Biotechnology Separation Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 273 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球商业生物技术分离系统市场预计将达到 310 亿美元

商业生物技术分离系统的全球市场预计 2023 年为 253 亿美元，预计到 2030 年将达到 310 亿美元，2023 年至 2030 年复合年增长率为 2.9%。传统方法是本报告分析的细分市场之一，预计复合年增长率为 2.7%，到分析期结束时将达到 190 亿美元。在分析期间，「现代方法」部分预计将以 3.3% 的复合年增长率成长。

美国市场预计69亿美元，中国预计复合年增长率4.8%

到 2023 年，美国商业生物技术分离系统市场预计将达到 69 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达60亿美元，2023-2030年分析期间复合年增长率为4.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 1.6% 和 2.4%。在欧洲，德国的复合年增长率预计为 2.0%。

全球商业生物技术分离系统市场—主要趋势与驱动因素总结

商业生物技术分离系统对于生物分子和蛋白质的精製和分析至关重要，并在製药、农业和能源等多个领域中发挥至关重要的作用。由于分离技术的不断进步和全球对生物製药的需求不断增加，这些先进的系统变得至关重要。为了遵守 FDA 等监管机构制定的严格的良好生产规范 (GMP) 准则，对复杂分离方法的需求不断增长，推动了市场成长。最近的趋势包括Sony Corporation的 SFA-生命科学云平台和 Tosoh Bioscience GmbH 的 Octave BIO 多管柱层析法系统等系统的开发。这些创新提高了生物技术分离的效率，满足不断发展的行业标准，并支持快速成长的生物分子和蛋白质市场。

生物技术分离系统的采用和扩展是由几个关键因素驱动的，确保其在生物技术领域的相关性和效用不断增强。特别是慢性病的流行和个人化医疗的推广正在增加对生物製药的需求，需要有效的分离系统来精製治疗性生物分子。强化层析法、过滤和离心等分离方法的技术进步使得复杂的生物混合物更有效地处理。此外，严格的法规遵循要求生物技术产品具有高纯度和高品质，从而增加了对先进分离製程的需求。生物技术领域的扩张和研发的大量投资，特别是在金砖四国等新兴市场，进一步刺激了对先进分离技术的需求。

新的趋势和驱动力，例如新生技药品的引入以及分离系统的应用从传统生物製药扩展到食品、饮料、化妆品和农业等行业，凸显了生物技术分离系统的应用范围不断扩大。材料科学的进步正在增强分离过程的性能并提高纯度水平和产量，这对于生物技术生产至关重要。将物联网、人工智慧和机器学习等数位技术整合到分离系统中可以简化操作并实现流程的即时监控和优化。全球健康危机也凸显了分离系统在治疗药物和疫苗生产中的关键作用，凸显了它们在疫情防范和应对中的重要性。最后，资金筹措和创业投资投资的增加使得尖端分离技术的引入成为可能，促进创新并促进先进系统的收购，进一步推动市场的成长和发展。

受访企业范例（46家知名企业）

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-7990

Global Commercial Biotechnology Separation Systems Market to Reach US$31.0 Billion by 2030

The global market for Commercial Biotechnology Separation Systems estimated at US$25.3 Billion in the year 2023, is expected to reach US$31.0 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Conventional Method, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$19.0 Billion by the end of the analysis period. Growth in the Modern Method segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 4.8% CAGR

The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Commercial Biotechnology Separation Systems Market - Key Trends and Drivers Summarized

Commercial biotechnology separation systems are essential for the purification and analysis of biomolecules and proteins, playing a pivotal role in various sectors including pharmaceuticals, agriculture, and energy. These advanced systems have become integral due to continuous developments in separation technologies and a global increase in demand for biopharmaceutical products. The market's growth is buoyed by the rising need for sophisticated separation methods to adhere to stringent Good Manufacturing Practices (GMP) guidelines set by regulatory bodies like the FDA. Recent advancements include the development of systems such as the SFA - Life Sciences Cloud Platform by Sony Corporation and the Octave BIO multi-column chromatography system by Tosoh Bioscience GmbH. These innovations enhance the efficiency of biotechnological separations, catering to evolving industry standards, and support the burgeoning market for biomolecules and proteins.

The adoption and expansion of biotechnology separation systems are driven by several critical factors, ensuring their increasing relevance and utility across the biotechnology field. Notably, the growing prevalence of chronic diseases and the push towards personalized medicine have escalated the demand for biopharmaceuticals, necessitating effective separation systems for therapeutic biomolecule purification. Technological advancements in separation methods, such as enhanced chromatography, filtration, and centrifugation, allow for more efficient handling of complex biological mixtures. Additionally, strict regulatory compliance mandates high purity and quality in biotechnological products, bolstering the need for advanced separation processes. The expansion of the biotechnology sector, especially in emerging markets like the BRIC countries, coupled with significant investments in research and development, further stimulates the need for sophisticated separation technologies.

Emerging trends and drivers such as the introduction of new biologics and the expansion of separation system applications beyond traditional biopharmaceuticals into industries like food, beverage, cosmetics, and agriculture, highlight the broadening scope of biotechnology separation systems. Advances in material science enhance the performance of separation processes, increasing purity levels and yields crucial for biotechnological production. The integration of digital technologies, including IoT, AI, and machine learning, into separation systems streamlines operations, enabling real-time monitoring and optimization of processes. Global health crises have also spotlighted the vital role of separation systems in manufacturing therapeutics and vaccines, emphasizing their importance in pandemic preparedness and response. Lastly, increased funding and venture capital investments are enabling the adoption of cutting-edge separation technologies, fostering innovation and facilitating the acquisition of advanced systems, further driving the market's growth and evolution.

Select Competitors (Total 46 Featured) -

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Commercial Biotechnology Separation Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Biopharmaceuticals Spurs Growth of Biotechnology Separation Systems
    • Advancements in Chromatography Techniques Propel Market Growth
    • Increasing Focus on Personalized Medicine Expands Addressable Market Opportunity
    • Technological Innovations in Membrane Filtration Strengthen Business Case for Advanced Separation Systems
    • Government Regulations and Quality Standards Generate Demand for High-Precision Separation Technologies
    • Rising Adoption of Single-Use Technologies Drives Market Adoption
    • Emergence of Continuous Bioprocessing Throws the Spotlight on Efficient Separation Solutions
    • Growing Use of Monoclonal Antibodies Accelerates Demand for Advanced Separation Techniques
    • Increasing Investment in Biotech R&D Sustain Market Growth
    • Adoption of Automation and Robotics in Bioprocessing Fuels Demand for Integrated Separation Systems
    • Expansion of Biosimilars Market Propels Growth of Biotechnology Separation Systems
    • Growing Applications in Cell and Gene Therapy Expand Market Opportunities
    • Impact of Digital Transformation on Process Optimization
    • Increasing Focus on Process Analytical Technology (PAT) Drives Demand for Real-Time Separation Monitoring
    • Challenges in Scale-Up and Commercial Manufacturing Create Opportunities for Modular Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Commercial Biotechnology Separation Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Modern by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Food & Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION